Diagnostic accuracy of 18F-FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma. 2017

Verena Ruhlmann, and Thorsten D Poeppel, and Johannes Veit, and James Nagarajah, and Lale Umutlu, and Thomas K Hoffmann, and Andreas Bockisch, and Ken Herrmann, and Wolfgang Sauerwein
Department of Nuclear Medicine, University Duisburg-Essen, Medical Faculty, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany. verena.ruhlmann@uk-essen.de.

The aim of this study was to evaluate the value of 18F-FDG PET/CT (PET/CT) and MRI for local and/or whole-body restaging of adenoid cystic carcinoma of the head and neck (ACC). Thirty-six patients with ACC underwent conventional MRI of the head and neck and a whole-body PET/CT and were analysed with regards to detection of a local tumor recurrence, lymph node or distant metastases. A consensus interpretation of all available imaging data was used as reference standard. Sensitivity, specificity, diagnostic accuracy, positive and negative predictive values were calculated for MRI and PET/CT. The sensitivity of PET/CT and MRI was 96% (89%), specificity 89% (89%), PPV 96% (96%), NPV 89% (73%) and accuracy 94% (89%) for detection of local tumors. Additionally, PET/CT revealed lymph node metastases in one patient and distant metastases in 9/36 patients. In three patients secondary primaries were found. Whole-body PET/CT in addition to MRI of the head and neck improves detection of local tumour and metastastic spread in ACC.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003528 Carcinoma, Adenoid Cystic Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed) Cylindroma,Adenocystic Carcinoma,Adenocystic Carcinomas,Adenoid Cystic Carcinoma,Adenoid Cystic Carcinomas,Carcinoma, Adenocystic,Carcinomas, Adenocystic,Carcinomas, Adenoid Cystic,Cylindromas,Cystic Carcinoma, Adenoid,Cystic Carcinomas, Adenoid
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

Verena Ruhlmann, and Thorsten D Poeppel, and Johannes Veit, and James Nagarajah, and Lale Umutlu, and Thomas K Hoffmann, and Andreas Bockisch, and Ken Herrmann, and Wolfgang Sauerwein
September 2021, Clinical nuclear medicine,
Verena Ruhlmann, and Thorsten D Poeppel, and Johannes Veit, and James Nagarajah, and Lale Umutlu, and Thomas K Hoffmann, and Andreas Bockisch, and Ken Herrmann, and Wolfgang Sauerwein
February 2016, Clinical nuclear medicine,
Verena Ruhlmann, and Thorsten D Poeppel, and Johannes Veit, and James Nagarajah, and Lale Umutlu, and Thomas K Hoffmann, and Andreas Bockisch, and Ken Herrmann, and Wolfgang Sauerwein
March 2015, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Verena Ruhlmann, and Thorsten D Poeppel, and Johannes Veit, and James Nagarajah, and Lale Umutlu, and Thomas K Hoffmann, and Andreas Bockisch, and Ken Herrmann, and Wolfgang Sauerwein
May 2022, Clinical nuclear medicine,
Verena Ruhlmann, and Thorsten D Poeppel, and Johannes Veit, and James Nagarajah, and Lale Umutlu, and Thomas K Hoffmann, and Andreas Bockisch, and Ken Herrmann, and Wolfgang Sauerwein
November 2007, European journal of nuclear medicine and molecular imaging,
Verena Ruhlmann, and Thorsten D Poeppel, and Johannes Veit, and James Nagarajah, and Lale Umutlu, and Thomas K Hoffmann, and Andreas Bockisch, and Ken Herrmann, and Wolfgang Sauerwein
January 2022, Hellenic journal of nuclear medicine,
Verena Ruhlmann, and Thorsten D Poeppel, and Johannes Veit, and James Nagarajah, and Lale Umutlu, and Thomas K Hoffmann, and Andreas Bockisch, and Ken Herrmann, and Wolfgang Sauerwein
December 2015, Nuclear medicine communications,
Verena Ruhlmann, and Thorsten D Poeppel, and Johannes Veit, and James Nagarajah, and Lale Umutlu, and Thomas K Hoffmann, and Andreas Bockisch, and Ken Herrmann, and Wolfgang Sauerwein
January 2024, American journal of nuclear medicine and molecular imaging,
Verena Ruhlmann, and Thorsten D Poeppel, and Johannes Veit, and James Nagarajah, and Lale Umutlu, and Thomas K Hoffmann, and Andreas Bockisch, and Ken Herrmann, and Wolfgang Sauerwein
May 2024, Clinical nuclear medicine,
Verena Ruhlmann, and Thorsten D Poeppel, and Johannes Veit, and James Nagarajah, and Lale Umutlu, and Thomas K Hoffmann, and Andreas Bockisch, and Ken Herrmann, and Wolfgang Sauerwein
June 2017, Annals of nuclear medicine,
Copied contents to your clipboard!